Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Denise van Hout"'
Autor:
Denise van Hout, Paul Hutchinson, Marta Wanat, Caitlin Pilbeam, Herman Goossens, Sibyl Anthierens, Sarah Tonkin-Crine, Nina Gobat
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0245182 (2022)
BackgroundWorking under pandemic conditions exposes health care workers (HCWs) to infection risk and psychological strain. A better understanding of HCWs' experiences of following local infection prevention and control (IPC) procedures during COVID-1
Externí odkaz:
https://doaj.org/article/cc9dbad2c0594782b7e6a36146d60cbe
Autor:
Denise van Hout, Tess D Verschuuren, Patricia C J Bruijning-Verhagen, Thijs Bosch, Anita C Schürch, Rob J L Willems, Marc J M Bonten, Jan A J W Kluytmans
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227604 (2020)
BACKGROUND:Knowledge on the molecular epidemiology of Escherichia coli causing E. coli bacteremia (ECB) in the Netherlands is mostly based on extended-spectrum beta-lactamase-producing E. coli (ESBL-Ec). We determined differences in clonality and res
Externí odkaz:
https://doaj.org/article/6274c15f7a59447eb7a19e468a8b4bae
Autor:
Marc J. M. Bonten, Hetty E. M. Blok, Patricia Bruijning-Verhagen, Denise van Hout, Annet Troelstra
Publikováno v:
Journal of Hospital Infection. 109:32-39
SUMMARY Background In Dutch hospitals a 6-point questionnaire is currently mandatory for risk assessment to identify carriers of multidrug-resistant organisms (MDRO) at the time of hospitalization. Presence of one or more risk factors is followed by
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:3135-3143
Background Colistin is an antibiotic that targets the LPS molecules present in the membranes of Gram-negative bacteria. It is used as a last-resort drug to treat infections with MDR strains. Colistin is also used in selective decontamination of the d
Autor:
Denise van Hout, Axel B. Janssen, Judith Vlooswijk, C H Edwin Boel, Rob J. Rentenaar, Marc J. M. Bonten
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
European Journal of Clinical Microbiology & Infectious Diseases, 39(2), 265. Springer Verlag
European Journal of Clinical Microbiology & Infectious Diseases, 39(2), 265. Springer Verlag
The objective of this study was to determine the value of using SuperPolymyxin™ selective medium (ELITech Group, Puteaux, France) in addition to conventional non-selective inoculation methods in the detection of acquired colistin resistance in a Du
Colistin is an antibiotic that targets the lipopolysaccharides present in the membranes of Gram-negative bacteria. It is used as last-resort drug to treat infections with multidrug-resistant strains. Colistin is also used in selective decontamination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bb7dd394345b36fe8d229b4c77a510
Background In Dutch hospitals a 6-point questionnaire is mandatory for risk-assessment to identify carriers of multidrug-resistant organisms (MDRO) at the time of hospitalization. Presence of one or more risk factors is followed by microbiological cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4a611ed255024baae16b015bb7d920
https://doi.org/10.21203/rs.3.rs-16670/v1
https://doi.org/10.21203/rs.3.rs-16670/v1
Autor:
Marc J.M. Bonten, Rob J. L. Willems, Denise van Hout, Jan Kluytmans, Tess D. Verschuuren, Thijs Bosch, Anita C. Schürch, Patricia Bruijning-Verhagen
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227604 (2020)
PLoS ONE
PLoS ONE, 15(1). Public Library of Science
PLoS ONE
PLoS ONE, 15(1). Public Library of Science
BackgroundKnowledge on the molecular epidemiology of Escherichia coli causing E. coli bacteremia (ECB) in the Netherlands is mostly based on extended-spectrum beta-lactamase-producing E. coli (ESBL-Ec). We determined differences in clonality and resi
Autor:
Patricia Bruijning-Verhagen, Evelien A. N. Oostdijk, Denise van Hout, G. Ardine de Wit, Cornelis H. van Werkhoven, Marc J. M. Bonten, Anne Marie G. A. de Smet, Nienke L. Plantinga
Publikováno v:
BMJ Open
BMJ Open, 9(9). BMJ Publishing Group
BMJ Open, 9(9). BMJ Publishing Group
ObjectiveTo determine the cost-effectiveness of selective digestive decontamination (SDD) as compared to selective oropharyngeal decontamination (SOD) in intensive care units (ICUs) with low levels of antimicrobial resistance.DesignPost-hoc analysis
Autor:
Jan Kluytmans, Tess D. Verschuuren, Patricia Bruijning-Verhagen, Ad C. Fluit, Sabine C. de Greeff, Marc J. M. Bonten, Thijs Bosch, Anita C. Schürch, Rob J. L. Willems, Annemarie van 't Veen, Denise van Hout, E. Ascelijn Reuland
Background: Infections caused by E. coli cause considerable disease burden and range from frequently occurring and relatively innocent urinary tract infection (UTI) to severe bloodstream infection (BSI). The incidence of infections caused by ESBL-pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3efe3ff782296e362a6f7abf59a46154
https://doi.org/10.20944/preprints201902.0066.v1
https://doi.org/10.20944/preprints201902.0066.v1